Our Recommendations
- Recommendations on the delivery of health services for the prevention and care of sexually transmitted infections (2025)
- Outcomes of lenacapavir administration during pregnancy (2025)
- Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness (2025)
- Should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP? (2025)
- Systematic review of values and preferences for lenacapavir as pre-exposure prophylaxis and other forms of long-acting injectable PrEP (2025)
New Publications
- Recommendations on the delivery of health services for the prevention and care of sexually transmitted infections (2025)
- Outcomes of lenacapavir administration during pregnancy (2025)
- Lenacapavir-associated drug resistance: implications for scaling up long-acting PrEP (2025)
- Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness (2025)
- Should HIV testing services with rapid diagnostic tests and/or self-tests be used for initiation or continuation of injectable long-acting PrEP? (2025)
Filter
359
Featured
Recommendations
23
New Publications
43
Language
Document type
Guidelines
126
No document type
121
Studies & Reports
65
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Strategic & Response Plan
2
Brochures
1
Online Courses
1
Countries / Regions
Malawi
8
Global
8
Latin America and the Carribbean
7
South Africa
7
Africa
5
East and Southern Africa
5
Uganda
4
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Kenya
2
Lesotho
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
USA
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Argentina
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
53
Countries
30
Women & Child Health
8
Pharmacy & Technologies
3
Public Health
2
Capacity Building
1
Key Resources
1
Version 9.0
Octobre 2017
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Services de depistage du VIH
Note d'orientation
Decembre 2016
Technical Update
HIV Treatment
July 2017
WHO/UNAIDS 2017 | Statement
Choko AT et al. Journal of the International AIDS Society 2017, 20:21610 http://www.jiasociety.org/index.php/jias/article/view/21610 | http://dx.doi.org/10.7448/IAS.20.1.21610
Training materials for healthcare workers
Women advancing the end of AIDS
Une approche intégrée de la santé et des droits humains est essentielle pour veiller à la dignité et au bien-être des femmes vivant avec le VIH.
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
HIV drug resistance , Users Manual
December 2017
El esfuerzo por garantizar la dignidad y el bienestar de las mujeres que viven con VIH se centra en un enfoque integrado de la salud y los derechos humanos.
Policy Brief
Consolidated Guidelines
Updated 2016
WHO/HIV/2017.05
Servicios de detección del VIH
Sinopsis de política
Diciembre del 2016
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
